Paromomycin and NEOMYCIN B (cas 119-04-0) derived cationic lipids: Synthesis and transfection studies
-
Add time:08/31/2019 Source:sciencedirect.com
Cationic lipid-based nonviral gene delivery is an attractive approach for therapeutic gene transfer. Basically, gene transfection can be achieved by using synthetic vectors that compact DNA, forming cationic lipoplexes which can interact with the cell plasma membrane by electrostatic interactions. Among the basic components of any cationic lipid, the type of cationic headgroup has been shown to have a major role in transfection efficiency. We have previously reported the DNA transfection potential of vectors characterized by a kanamycin A headgroup. The encouraging transfection results obtained with these compounds prompted us to evaluate the potential of cationic lipids bearing headgroups based on other aminoglycosides. Thus, we herein report the synthesis and gene transfection properties of novel cationic lipids consisting of cholesteryl or dioleyl moieties linked, via various spacers, to paromomycin or NEOMYCIN B (cas 119-04-0) headgroups. Our results confirm that these new aminoglycoside-based cationic lipids are efficient for gene transfection both in vitro and into the mouse airways in vivo. We also investigated physico-chemical properties of the DNA complexes formed by this particular type of synthetic vectors in order to better understand their structure–activity relationships.
We also recommend Trading Suppliers and Manufacturers of NEOMYCIN B (cas 119-04-0). Pls Click Website Link as below: cas 119-04-0 suppliers
Prev:Synthesis and antibacterial activity of amphiphilic lysine-ligated NEOMYCIN B (cas 119-04-0) conjugates
Next:SPR sensing of small molecules with modified RNA aptamers: Detection of NEOMYCIN B (cas 119-04-0)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Identification of NEOMYCIN B (cas 119-04-0)-binding site in T box antiterminator model RNA09/04/2019
- Efficient synthesis of NEOMYCIN B (cas 119-04-0) related aminoglycosides09/03/2019
- Integrated nanotechnology of synergism-sterilization and removing-residues for neomycin through nano-Cu2O09/02/2019
- SPR sensing of small molecules with modified RNA aptamers: Detection of NEOMYCIN B (cas 119-04-0)09/01/2019
- Synthesis and antibacterial activity of amphiphilic lysine-ligated NEOMYCIN B (cas 119-04-0) conjugates08/30/2019
- Quantification of neomycin in rubella vaccine by off/on metal ion mediated photoluminescence from functionalized graphene quantum dots08/29/2019
- Neomycin-dependent hammerhead ribozymes for the direct control of gene expression in Saccharomyces cerevisiae08/28/2019
- Original articlePRISM study: Comparison of a nystatin-neomycin-polymyxin B combination with miconazole for the empirical treatment of infectious vaginitisÉtude PRISM : comparaison de l’association nystatine-néomycine-polymyxine B versus miconazole dans le traitement probabiliste de la vaginite infectieuse☆08/27/2019
- NEOMYCIN B (cas 119-04-0)-cyclen conjugates and their Zn(II) complexes as RNA-binding agents☆08/26/2019
-
Health and Chemical more >